Skip to main content
TipRanks
Go Ultimate75% OFF

Health In Tech, Inc. Class A (HIT) AI Stock Analysis

121 Followers
HIT

Health In Tech, Inc. Class A

(NASDAQ:HIT)

Select Model
Rating:43Neutral
Price Target:$0.38â–¼(-3.54% Downside)
Action:reiterated
Date:11/14/26

The score is held down primarily by sharply weaker financial performance (large losses, margin compression, and negative operating/free cash flow) and bearish technicals (price below all major moving averages with negative MACD). Earnings-call messaging provides some offset via revenue outlook, pipeline, and improving cash usage, but execution risks (conversion rates, delays, and limited 2027 visibility) remain high; valuation support is limited by a negative P/E and no dividend.

Positive Factors
Conservative leverageVery low leverage reduces refinancing pressure and preserves flexibility to fund platform development or absorb operating volatility. That balance-sheet cushion is a durable advantage while management works to commercialize new offerings, although it does not offset current losses.
Negative Factors
Losses and cash burnThe shift to substantial losses and negative operating cash flow weakens internal funding capacity and increases dependence on successful commercialization or external financing. Persistent cash burn can constrain investment choices and make the business less resilient if growth initiatives take longer to mature.

Health In Tech, Inc. Class A (HIT) vs. SPDR S&P 500 ETF (SPY)

-75%-50%-25%0%25%50%HIT-71.38%SPY+15.52%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$21.20M
Dividend Yield
―
Average Volume (3M)
173.57K
Price to Earnings (P/E)
-2.1
Beta (1Y)
1.29
Revenue Growth
0.65%
EPS Growth
-814.29%
Country
US
Employees
89
Sector
General
Sector Strength
55
Industry
Software - Application

Health In Tech, Inc. Class A Business Overview & Revenue Model

Company Description

Health In Tech, Inc. operates as a cutting-edge insurance technology provider. The company delivers a range of specialized insurance solutions for smaller enterprises, such as value-based pricing strategies, group insurance captives, localized commun...

Health In Tech, Inc. Class A Earnings Call Summary

Earnings Call Date:Nov 12, 2026(Q3-2026)|% Change Since:-26.17%|Next Earnings Date:Mar 22, 2027
Earnings Call SentimentNeutral

The call presented a mixed, transitional outlook. Health In Tech highlighted a growing distribution network, substantial pipeline and contracted-revenue visibility, improving operating cash flow, a stronger cash position and multiple product initiatives targeted for commercialization. However, these positives were offset by declining reported revenue, gross-margin compression, significant credit-loss provisions, negative EBITDA and net losses, delayed commercialization, low historical pipeline conversion and the absence of finalized 2027 guidance. Management expressed confidence in the opportunity but acknowledged that execution and conversion remain the central challenges.

Positive Updates

Leadership Transition Supports Execution Focus
Health In Tech separated the Executive Chairman and CEO roles, with Tim Johnson continuing to focus on long-term strategy, technology innovation and product development, while Sanjay Shrestha leads day-to-day operations, commercial execution, organizational scaling and potential strategic acquisitions or partnerships.

Negative Updates

Revenue Declined Year Over Year
Third-quarter revenue was $6.6 million compared with $8.5 million a year earlier, and first-nine-month revenue was $23.4 million compared with $25.8 million in the prior-year period. The company updated its full-year 2026 revenue outlook to approximately $30 million.

Company Guidance

Health In Tech updated its full year 2026 revenue outlook to approximately $30 million and said gross margin would maintain in the range of 45% to 50% in the coming quarters; its $153.8 million pipeline carries an expected conversion rate of 3% to 7%, meaning it would generate $9.3 million to $10.7 million revenue for the 3 months, while approximately 70% of the approximately $150 million potential annualized revenue pipeline was associated with January 1, 2027. The company’s goal is to complete the first end-to-end Three-Year Rate Stabilization Program launch by the end of 2026, launch the HitRix minimum viable product in the first quarter of 2027, and launch an initial HITChain minimum viable product during the second half of 2027; management said HitRix is probably Q2 opportunity at the earliest, HITChain is a second half 2027 opportunity, and expected further improvement in operating cash flow as it commercializes the new service and product in 2027, but it is not presenting a finalized 2027 plan or revenue outlook today.

Health In Tech, Inc. Class A Financial Statement Overview

Summary

Operating results and cash generation deteriorated sharply: TTM swung to a large net loss (net margin ~-37%) with notable gross-margin compression, and operating/free cash flow turned negative (OCF ~-$6.8M; FCF ~-$7.6M). The main offset is a conservatively levered balance sheet (very low debt-to-equity), but losses and cash burn are the dominant near-term risk.

Income Statement

34Negative

Balance Sheet

73Positive

Cash Flow

29Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022
Income Statement
Total Revenue30.92M33.33M19.49M19.15M5.77M
Gross Profit15.90M20.94M15.44M16.85M5.44M
EBITDA-13.26M2.57M1.93M3.76M205.58K
Net Income-11.47M1.28M670.48K2.48M79.74K
Balance Sheet
Total Assets28.03M23.09M15.77M11.50M28.56M
Cash, Cash Equivalents and Short-Term Investments10.13M7.67M7.85M2.42M1.49M
Total Debt6.72M139.81K206.69K1.92M316.09K
Total Liabilities16.89M5.98M2.60M5.41M27.14M
Stockholders Equity12.85M17.11M13.17M6.09M1.05M
Cash Flow
Free Cash Flow-7.57M-56.11K1.28M384.52K-436.63K
Operating Cash Flow-6.83M3.13M2.18M1.53M782.75K
Investing Cash Flow-2.57M-3.13M-836.75K-1.94M-1.22M
Financing Cash Flow11.50M-187.39K4.09M1.34M1.88M

Health In Tech, Inc. Class A Technical Analysis

Technical Analysis SentimentNegative
Last Price0.40

Price Trends

50DMA0.72Negative
100DMA0.89Negative
200DMA1.11Negative

Market Momentum

MACD-0.06Positive
RSI26.85Positive
STOCH28.50Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HIT, the sentiment is Negative. The current price of 0.40 is below the 20-day moving average (MA) of 0.57, below the 50-day MA of 0.72, and below the 200-day MA of 1.11, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 26.85 is Positive, neither overbought nor oversold. The STOCH value of 28.50 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HIT.

Health In Tech, Inc. Class A Risk Analysis

Health In Tech, Inc. Class A disclosed 39 risk factors in its most recent earnings report. Health In Tech, Inc. Class A reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

2 New Risks
1.Our ability to accurately perform underwriting proceduresQ2, 2026
2.Nasdaq may delist our securities from its exchange which could limit investors' ability to make transactions in its securities and subject us to additional trading restrictions.Q1, 2025

Health In Tech, Inc. Class A Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

HIT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
WFCFWFCF71Outperform$80.84M70.8112.28%―-0.66%-55.74%
RSSSRSSS68Neutral$67.86M22.5315.55%―-1.53%140.44%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
SSTISSTI49Neutral$109.37M-4.67-34.73%―-4.75%-108.66%
HITHIT43Neutral$25.83M-2.13-64.51%―0.65%-814.29%

* General Sector Average

Performance Comparison

-50%0%50%HITWFCFSSTIRSSSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
HIT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
HITHealth In Tech, Inc. Class A0.40-0.98-71.38%
WFCFWhere Food Comes From, Inc.16.304.6139.44%
SSTISoundthinking, Inc.8.262.1334.75%
RSSSResearch Solutions 2.01-0.79-28.21%

Health In Tech, Inc. Class A Corporate Events

Executive/Board ChangesFinancial DisclosuresProduct-Related Announcements

Health In Tech Reports Third-Quarter Revenue and Losses

Negative
Nov 13, 2026

On November 12, 2026, Health In Tech reported unaudited third-quarter revenue of $6.6 million, down from $8.5 million a year earlier, while nine-month revenue was $23.4 million versus $25.8 million. Distribution partners reached 984 as of September 3...

Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures

Health In Tech Discusses Q3 Results and Leadership Changes

Negative
Nov 13, 2026

On Nov. 12, 2026, Health In Tech hosted a conference call covering its operating and financial results for the quarter ended Sept. 30, 2026. Executives said the company had invested during 2026 in its sales and distribution network, industry relation...

Business Operations and StrategyProduct-Related Announcements

Health In Tech Details AI-Enabled Marketplace in Investor Presentation

Positive
Nov 13, 2026

On November 12, 2026, Health In Tech prepared an investor presentation for use by company officers and representatives at conferences and meetings. The presentation described an AI-enabled marketplace for self-funded health plans and cited bindable q...

Executive/Board ChangesPrivate Placements and FinancingShareholder Meetings

Health In Tech Holds Annual Meeting, Approves Key Proposals

Neutral
Nov 12, 2026

On November 10, 2026, Health In Tech held its annual meeting, where stockholders elected five director nominees, including new nominee Tim Cortes, to serve until the 2027 annual meeting or until their successors were elected and qualified.Stockholder...

Private Placements and FinancingRegulatory Filings and Compliance

Health In Tech Completes Second Prepaid Advance Closing

Neutral
Nov 6, 2026

On November 2, 2026, Health In Tech, Inc. completed its second pre-paid advance closing with YA II PN, Ltd., issuing a $3.0 million promissory note at a 5% purchase-price discount and receiving $2.85 million in gross proceeds. The related Form S-3 re...

Business Operations and StrategyExecutive/Board ChangesShareholder Meetings

Health In Tech Names Sanjay Shrestha as New CEO

Positive
Oct 26, 2026

On October 20, 2026, Health In Tech appointed former Plug Power president and seasoned capital markets executive Sanjay Shrestha as Chief Executive Officer, while founder Tim Johnson moved into the role of Executive Chairman to concentrate on long-te...

Executive/Board ChangesDelistings and Listing ChangesRegulatory Filings and ComplianceShareholder MeetingsStock Split

Health In Tech Faces Nasdaq Listing Compliance Challenges

Negative
Oct 16, 2026

On October 14, 2026, Health In Tech disclosed that Nasdaq has determined the company is out of compliance with independent director and audit committee rules following the August 10, 2026 resignation of director Sanjay Shrestha, leaving its four-memb...

Business Operations and StrategyFinancial DisclosuresProduct-Related Announcements

Health In Tech Launches HitRix AI Insurance Platform

Neutral
Sep 30, 2026

On September 30, 2026, Health In Tech launched HitRix, an AI-powered platform designed to modernize the nearly $1 trillion U.S. self-funded health insurance market by streamlining large-group submissions and multi-market quoting in a single secure en...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026